May
10
2018
On demand

Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove

Watch this On Demand webinar which explores the close relationship between automation and disposables as critical elements that allow Cell Therapy companies to manufacture cost-effective therapies. We’ll be hearing from Natasha Boghosian, Product Manager for Cell Therapy at Saint-Gobain, USA and Brian Hanrahan, Program Manager at Invetech as they discuss the critical considerations for successful cell therapy automation, including materiel selection, system design, and validation.

This webinar provides insight into:

  • How to optimize material selection for your single-use system;
  • The critical steps to successful validation;
  • The future of automation and emerging technologies.

Natasha Boghosian

Product Manager, Cell Therapy, Saint-Gobain, USA

Natasha Boghosian is the Product Manager for Cell Therapy within Saint-Gobain’s Bioprocessing Solutions business unit. Natasha joined Saint-Gobain in 2012 and previously served as a Process Development Engineer within the CertainTeed division and a Research Engineer within the Performance Plastics division. Natasha received her B.S. in Chemical Engineering from the Pennsylvania State University where she supplemented her studies through research internships in bioengineering and immunology.


Brian Hanrahan

Program Manager, Cell Therapy, Invetech, USA

Brian Hanrahan has more than 15 years of product development experience across the biomedical and cell therapy industries. In his current role, Brian is the Manager of Invetech’s Cell Therapy Group in San Diego, CA, helping cell and advanced therapy companies across the globe realize clinical and commercial-scale cGMP manufacturing solutions. Brian has been a key contributor in building Invetech’s cell and advanced therapy capabilities and continues to have a deep involvement in projects ranging from the development of cell separation instruments to single-use, automated cell therapy production systems. Brian has a bachelor’s degree in Applied Science from RMIT University in Australia.

SPEAKERS

Natasha Boghosian
Consultant at Integrated Project Management Company, Inc.
Brian Hanrahan
Biotech Program Director at StarFish Medical

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
36
Days
7
Hrs
13
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
14
Days
7
Hrs
13
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
9
Days
7
Hrs
13
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
7
Days
7
Hrs
13
Min
Register

Strategic partnering to enable cell therapy commercialization

J Smith
X de Mollerat du Jeu
Jenessa Smith
Jenessa Smith
Associate Director of Process Development at ArsenalBio
Xavier de Mollerat du Jeu
Xavier de Mollerat du Jeu
Senior Director, R&D, Cell and Gene Therapy at Thermo Fisher Scientific
12 May 2022
Watch now